STOCK TITAN

Invesco Ltd. (QDEL) discloses 5.1% beneficial stake in QuidelOrtho

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Invesco Ltd. reports beneficial ownership of 3,470,656 shares of QuidelOrtho Corp common stock, representing 5.1% of the class as of 12/31/2025. Invesco has sole voting power over 3,450,932 shares and sole dispositive power over 3,470,656 shares, with no shared powers.

The shares are held of record by clients of Invesco’s investment advisers, including Invesco Advisers, Inc. and Invesco Capital Management LLC. Invesco certifies the holdings are in the ordinary course of business and not for the purpose of changing or influencing control of QuidelOrtho.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



Invesco Ltd.
Signature:Robert R. Leveille
Name/Title:Global Head of Compliance
Date:02/12/2026

FAQ

What ownership stake does Invesco Ltd. report in QuidelOrtho Corp (QDEL)?

Invesco Ltd. reports beneficial ownership of 3,470,656 QuidelOrtho Corp common shares, representing 5.1% of the outstanding class as of December 31, 2025. These shares are held for clients of its investment adviser subsidiaries, not directly by Invesco.

How much voting and dispositive power does Invesco have over QDEL shares?

Invesco has sole voting power over 3,450,932 QuidelOrtho shares and sole dispositive power over 3,470,656 shares. It reports no shared voting or shared dispositive power, indicating decisions are controlled solely through its advisory relationships for these client accounts.

Is Invesco’s QuidelOrtho (QDEL) position intended to influence control of the company?

Invesco certifies the QuidelOrtho shares were acquired and are held in the ordinary course of business. It states they were not acquired and are not held to change or influence control of QuidelOrtho, other than activities solely related to proxy nomination rules.

Who ultimately benefits from Invesco’s reported QDEL share ownership?

The economic benefits from Invesco’s QuidelOrtho holdings go to shareholders of the funds and client accounts managed by its advisers. No single individual has more than 5% economic ownership, and these clients receive dividends and sale proceeds on the reported securities.

Which Invesco entities are associated with the QuidelOrtho (QDEL) holdings?

The filing identifies Invesco Advisers, Inc. and Invesco Capital Management LLC as the subsidiaries through which the QuidelOrtho shares are held. Invesco Ltd. reports as a parent holding company with beneficial ownership through these investment adviser subsidiaries.

What type of reporting person is Invesco in this QuidelOrtho Schedule 13G?

Invesco is classified as a parent holding company or control person filing on Schedule 13G. It reports beneficial ownership through its investment adviser subsidiaries, consistent with holdings managed on behalf of multiple clients rather than directly on its own balance sheet.
Quidel

NASDAQ:QDEL

QDEL Rankings

QDEL Latest News

QDEL Latest SEC Filings

QDEL Stock Data

1.96B
66.77M
0.92%
117.99%
11.25%
Medical Devices
In Vitro & in Vivo Diagnostic Substances
Link
United States
SAN DIEGO